RecruitingNCT06587100
Wearable Activity Tracking to Curb Hospitalizations
Wearable Activity Tracking to Curb Hospitalizations (WATCH)
Sponsor
University of California, San Francisco
Enrollment
260 participants
Start Date
Apr 7, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Age >= 18.
- Eastern Cooperative Oncology Group (ECOG) performance status =< 2.
- Able to understand study procedures and to comply with them for the entire length of the study.
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
- Diagnosis of invasive malignancy.
- Able to ambulate independently (without the assistance of a cane or walker).
- Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement).
- Not a previous participant on this protocol for subsequent courses.
Exclusion Criteria2
- Participants bound to a wheelchair.
- Participants unable to ambulate independently (needing assistance of cane or walker).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEFitbit
Participants will wear Fitbit device
DEVICEApple HealthKit-based devices
Participants will wear personal device and share data with study team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06587100
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
NCT06126276182 locations
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
NCT060083923 locations
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069745 locations
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
NCT045656651 location